Merck’s Research Chief Saved Biotech Deal With Juicy PitchCaroline Chen
After a bidding war for a stake in a promising experimental drug, Merck & Co. received a disappointing phone call. It had lost.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.